መነሻ › የአውሮቴሊያል (ሽግግር ሴል) ካርሲኖማ › ማሳቹሴትስ › Boston
በBoston፣ MA ለየአውሮቴሊያል (ሽግግር ሴል) ካርሲኖማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየአውሮቴሊያል (ሽግግር ሴል) ካርሲኖማ የሚደረጉ 11 ጥናቶች በBoston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Exelixis Clinical Site #7, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Mass General Brigham, Boston
- Brigham and Women's Hospital, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Tufts Medical Center, Boston
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Massachusetts General Hospital, Boston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Dana Farber Cancer Institute, Boston
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Dana-Farber Cancer Institute, Boston
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Boston
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Dana Farber Cancer Institute, Boston
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Dana-Farber Cancer Institute, Boston
Sacituzumab Govitecan Plus EV in Metastatic UC
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute, Boston
በሌሎች ከተሞች ለየአውሮቴሊያል (ሽግግር ሴል) ካርሲኖማ የሚደረጉ ጥናቶች
- Nashville, TN23 ጥናቶች
- New York City, NY22 ጥናቶች
- Dallas, TX18 ጥናቶች
- Edison, NJ18 ጥናቶች
- Houston, TX18 ጥናቶች
- Los Angeles, CA17 ጥናቶች
- Queens, NY15 ጥናቶች
- Chicago, IL14 ጥናቶች
- Arlington, VA12 ጥናቶች
- San Antonio, TX11 ጥናቶች
- Austin, TX10 ጥናቶች
- Orange, CA10 ጥናቶች
በBoston ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር111 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር90 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)86 ጥናቶች
- የኮሎሬክታል ካንሰር63 ጥናቶች
- Metastatic Cancer63 ጥናቶች
- የሳንባ ካንሰር62 ጥናቶች
- የእንቁላል ካንሰር61 ጥናቶች
- የፕሮስቴት ካንሰር59 ጥናቶች
- ዲፕሬሽን52 ጥናቶች
- የኤንዶሜትሪየም ካንሰር50 ጥናቶች
- የልብ ድካም44 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ44 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።